entertainment -WSS

entertainment

author：leisure time 2025-09-30 05:07:27 - browse：3

Yichuan Cao/Sipa USA via AP Images

Gilead Sciences said Monday that Trodelvy, its “smart-bomb” medicine that combines an antibody with chemotherapy, did not significantly extend the lives of patients with metastatic non-small cell lung cancer when given after a first treatment failed.

The result, from a closely watched study called Evoke-01, will be seen as a disappointment by investors and oncologists alike.

Drugs like Trodelvy, known as antibody drug conjugates, are one of the hottest areas in oncology. The idea is that these medicines combine an antibody, which is triggered when it binds to a protein on a cancer cell, with a “payload” of chemotherapy that poisons the cancer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Why more medical students aren't specializing in primary care

WSS

JPM 2024: Nvidia claims we're in biological revolution. Are we?

FDA panel gives mixed vote on blood pressure devices

Study finds new variant for Parkinson’s in African populations

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Idaho abortion case may prompt more restrictions in other states

Drug firms test therapies to halt Alzheimer’s before symptoms arise

focus

entertainment

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

The SUPPORT Act is critical to fighting the opioid crisis

Trump demands the U.S. pay no more for drugs than other countries … again

Psilocybin's anti

In age of alternative facts, a scholarly course on calling out crap

Doulas covered by Medicaid under New York's new plan

Hepatitis C has a cure — but many Americans still lack access to it

Heart disease and mental health: A look at cardiac psychology

Wildfire smoke exposes gaps in outdoor worker protections

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Wikipedia

How Long Island became the ‘eugenics capital of the world’

New menopause drug shows promise in relief for hot flashes

Complete sequence of Y chromosome published for first time

In science, is the line between industry and academia shifting?

Generative AI mines health records to identify patients’ social needs

As pharma fights Medicare drug negotiation, hospitals, docs silent

Wikipedia

hotspot

knowledge

focus